Study: 82% Regain Weight After Stopping Mounjaro
Are GLP-1 drugs like Mounjaro flawed treatments creating lifelong dependency, or effective chronic condition management?
Above: A close-up of a Mounjaro KwikPen injection. Image credit: Matthew Horwood/Getty Images
The Spin
Narrative A
GLP-1 drugs like Mounjaro are fundamentally flawed miracle cures that trap patients in lifelong dependency. The shocking reality is that 82% of people regain significant weight after stopping, proving these medications don't actually cure obesity but merely mask it temporarily.
Narrative B
The tirzepatide study demonstrates exactly what effective obesity treatment looks like — continuous medical management of a chronic condition. Just like diabetes or hypertension require ongoing medication, obesity needs sustained treatment to maintain the remarkable health benefits these drugs provide.
Metaculus Prediction
© 2025 Improve the News Foundation. All rights reserved.Version 6.20.0
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.20.0